Search Results - "Närkiö, M"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Laryngeal cancer in Finland: A 5-year follow-up study of 366 patients by Haapaniemi, Aaro, Koivunen, Petri, Saarilahti, Kauko, Kinnunen, Ilpo, Laranne, Jussi, Aaltonen, Leena-Maija, Närkiö, Mervi, Lindholm, Paula, Grénman, Reidar, Mäkitie, Antti, Atula, Timo

    Published in Head & neck (01-01-2016)
    “…ABSTRACT Background The purpose of this study was to acquire nationwide data on the management and outcome of laryngeal squamous cell carcinoma (SCC) in…”
    Get full text
    Journal Article
  2. 2

    Cytolytic complement activity in otitis media with effusion by Närkiö‐Mäkelä, M., Meri, S.

    Published in Clinical and experimental immunology (01-06-2001)
    “…Otitis media with effusion (OME) is a chronic inflammation persisting in the middle ear cavity of at least 8 weeks duration. Middle ear effusion (MEE; n = 38),…”
    Get full text
    Journal Article
  3. 3

    Probiotics and respiratory and gastrointestinal tract infections in Finnish military conscripts - a randomised placebo-controlled double-blinded study by Kalima, K, Lehtoranta, L, He, L, Pitkäniemi, J, Lundell, R, Julkunen, I, Roivainen, M, Närkiö, M, Mäkelä, M J, Siitonen, S, Korpela, R, Pitkäranta, A

    Published in Beneficial microbes (01-09-2016)
    “…Military conscripts are susceptible to respiratory and gastrointestinal tract infections. In previous studies probiotics have shown potency to reduce upper…”
    Get more information
    Journal Article
  4. 4

    Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion by Närkiö-Mäkelä, M, Jero, J, Meri, S

    Published in Clinical and experimental immunology (01-06-1999)
    “…The aetiopathogenesis of chronic otitis media with effusion (OME) in children is not yet fully understood. OME is characterized by metaplasia of the epithelium…”
    Get full text
    Journal Article
  5. 5

    Complement-Regulator Factor H and Related Proteins in Otitis Media with Effusion by Närkiö-Mäkelä, Mervi, Hellwage, Jens, Tahkokallio, Olli, Meri, Seppo

    Published in Clinical immunology (Orlando, Fla.) (01-07-2001)
    “…Otitis media with effusion (OME) is a common disease in childhood. It is characterized by chronic inflammation in which the proinflammatory activity of the…”
    Get full text
    Journal Article
  6. 6

    Endoscopic Sinus Surgery or Caldwell-Luc Operation in the Treatment of Chronic and Recurrent Maxillary Sinusitis by Närkiö-mäkelä, M., Qvarnberg, Y.

    Published in Acta oto-laryngologica (1997)
    “…The treatment of chronic and recurrent maxillary sinusitis has been changed in recent years. The radical Caldwell-Luc approach has increasingly been replaced…”
    Get full text
    Journal Article
  7. 7

    Oral prednisolone is an effective adjuvant therapy for acute otitis media with discharge through tympanostomy tubes by Ruohola, Aino, Heikkinen, Terho, Jero, Jussi, Puhakka, Tuomo, Juvén, Taina, Närkiö-Mäkelä, Mervi, Saxén, Harri, Ruuskanen, Olli

    Published in The Journal of pediatrics (01-04-1999)
    “…Objective: To determine the efficacy of a short course of oral prednisolone as an adjuvant therapy for acute otitis media draining through tympanostomy tubes…”
    Get full text
    Journal Article
  8. 8

    Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion by Närkiö-Mäkelä, M, Teppo, A M, Meri, S

    Published in The Laryngoscope (01-10-2000)
    “…To analyze whether complement C3a anaphylatoxin, other C3 fragments, interleukin-1beta (IL-1beta), or tumor necrosis factor-alpha (TNF-alpha) contributes to…”
    Get full text
    Journal Article
  9. 9

    Complement C3 Cleavage and Cytokines Interleukin-1β and Tumor Necrosis Factor-α in Otitis Media With Effusion by Närkiö-Mäkelä, Mervi, Teppo, Anna-Maija, Meri, Seppo

    Published in The Laryngoscope (01-10-2000)
    “…Objectives To analyze whether complement C3a anaphylatoxin, other C3 fragments, interleukin‐1β (IL‐1β), or tumor necrosis factor‐α (TNF‐α) contributes to…”
    Get full text
    Journal Article
  10. 10